☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19
April 29, 2020
Novartis' Cosentyx (secukinumab) Receives EC's Approval for Axial Spondyloarthritis Spectrum Marking its Fourth Indication in EU
April 29, 2020
BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany
April 29, 2020
Astellas Signs a Three-Year Research Alliance with Harvard University Across Multiple Therapeutic Areas
April 29, 2020
Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia
April 29, 2020
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Additional Recommended Dose of 400 mg Every Six Weeks for All...
April 29, 2020
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions